John Glasspool, CEO of Anthos Therapeutics discusses their lead product, abelacimab, an anticoagulant in development for the prevention of thrombosis.
Priya Kishnani, MD, Chen Family Professor of Pediatrics, Chief of the Division of Medical Genetics at Duke University Medical Center and Medical Directo...
Yolanda Lawson, MD, Board Certified OB/GYN and Associate Attending at Baylor University Medical Center discusses cervical cancer which typically develop...
Shambhu Aryal, MD, FCCP, Medical Director, Lung Transplant Program and Director, Inova Sarcoidosis Center, Inova Medical Group discusses the results of ...
Dr. Martin Kolb, Director of the Division of Respirology at the Department of Medicine at McMaster University and an expert on interstitial lung disease discusses...
Elizabeth Holt, MD, FACE, Head of Global Medical, Clinical, and Safety at LifeScan, a global leader in glucose monitoring and diabetes management, discu...
Are you confused about how health insurance works in Australia? Learn more on Health Professional Radio.
Allitia DiBernardo, M.D., Vice President, Global Medical Affairs, Neuroscience, Global Commercial Strategy Organization (GCSO) at Janssen discusses a no...
Axel Dignass, M.D., Ph.D., Head of the Department of Medicine I and Professor of Medicine and Gastroenterology at the Agaplesion Markus Hospital, Goet...
Janowitz Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai, and the Mount Sinai Hospital discusses findings from the Phase 2 G...